Your browser doesn't support javascript.
loading
Decreased tacrolimus plasma concentrations during HCV therapy: a drug-drug interaction or is there an alternative explanation?
Smolders, E J; Pape, S; de Kanter, C T M M; van den Berg, A P; Drenth, J P H; Burger, D M.
Affiliation
  • Smolders EJ; Department of Pharmacy, radboud university medical center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands. Electronic address: Elise.Smolders@radboudumc.nl.
  • Pape S; Department of Gastroenterology and Hepatology, radboud university medical center, Nijmegen, The Netherlands.
  • de Kanter CT; Department of Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.
  • van den Berg AP; Department of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, The Netherlands.
  • Drenth JP; Department of Gastroenterology and Hepatology, radboud university medical center, Nijmegen, The Netherlands.
  • Burger DM; Department of Pharmacy, radboud university medical center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands.
Int J Antimicrob Agents ; 49(3): 379-382, 2017 Mar.
Article in En | MEDLINE | ID: mdl-28185946

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Plasma / Tacrolimus / Hepatitis C, Chronic / Drug Interactions / Immunosuppressive Agents Limits: Aged / Humans / Male / Middle aged Language: En Journal: Int J Antimicrob Agents Year: 2017 Document type: Article Country of publication: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Plasma / Tacrolimus / Hepatitis C, Chronic / Drug Interactions / Immunosuppressive Agents Limits: Aged / Humans / Male / Middle aged Language: En Journal: Int J Antimicrob Agents Year: 2017 Document type: Article Country of publication: Netherlands